The Toronto-Dominion Bank
TD
BCE Inc
BCE
Enbridge Inc
ENB
Power Corporation of Canada
POW
TC Energy Corp
TRP
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidate is L-DOS47 for Tumor Defence Breaker is in clinical trials for pancreatic cancer.